Hanyang University Medical Center Arthritis Network
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00418405|
Recruitment Status : Unknown
Verified January 2007 by Hanyang University.
Recruitment status was: Not yet recruiting
First Posted : January 4, 2007
Last Update Posted : January 4, 2007
Rheumatoid arthritis is a relatively common autoimmune disease that affects about 1% of the population. Its impact on health-related quality of life of the affected patients and the national medical cost are enormous. However, a systemic prospective cohort study of rheumatoid arthritis has not yet been established in Korea, so data on characteristics and prognosis of Korean rheumatoid arthritis and their response to therapy and adverse events are limited. Therefore establishment of large prospective cohort of Korean rheumatoid arthritis is imperative.
With inauguration of a steadfast prospective cohort of Korean rheumatoid arthritis patients in The Hospital for Rheumatic Diseases at Hanyang University, where patients gather from all over Korea forming the largest and most diverse patient pool in Korea, we will be able to define the characteristics and prognosis of Korean rheumatoid arthritis patients and gather information on treatment response and adverse events. This will eventually lead to improvement of health-related quality of life in Korean rheumatoid arthritis patients and provide opportunity for reliable comparison study with research institutes from other countries. The data gathered through the cohort will provide valuable foundational information for the genetic studies, pharmacological economic analyses, and standard treatment guidelines of Korean rheumatoid arthritis patients.
|Condition or disease|
This study is a longitudinal prospective cohort of Korean rheumatoid arthritis patients comprising of all Korean adult rheumatoid arthritis patients satisfying the 1987 revised American College of Rheumatology (ACR) criteria and voluntarily agreeing to participate in the study with following objectives;
- Gather information on treatment response and adverse events of various pharmacological therapies for treatment of Korean rheumatoid arthritis patients
- Identify the incidence and mortality rates of concurrent diseases including the cardiovascular & gastrointestinal diseases and assess the contributing factors involved
Enrich understanding of disease characteristics, treatment response and adverse events in Korean rheumatoid arthritis to promote health and increase the health-related quality of life in Korean rheumatoid arthritis patients
|Study Type :||Observational|
|Enrollment :||1500 participants|
|Observational Model:||Defined Population|
|Observational Model:||Natural History|
|Official Title:||Hanyang University Medical Center Arthritis Network|
|Study Start Date :||January 2007|
|Study Completion Date :||January 2012|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00418405
|Contact: Sang-Cheol Bae, MD, PhD, MPHfirstname.lastname@example.org|
|Contact: Eun-Kyung Joo, BS, RNemail@example.com|
|Korea, Republic of|
|The Hospital for Rheumatic Diseases, Hanyang University||Not yet recruiting|
|Seoul, Korea, Republic of, 133-792|
|Principal Investigator: Sang-Cheol Bae, MD, PhD, MPH|
|Principal Investigator:||Sang-Cheol Bae, MD, PhD, MPH||Hanyang University|